MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
52.31
+1.94 (3.85%)
At close: Jun 26, 2026, 4:00 PM EDT
53.25
+0.94 (1.79%)
After-hours: Jun 26, 2026, 7:29 PM EDT
MBX Biosciences Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for MBX Biosciences stock have an average target of 73.11, with a low estimate of 56 and a high estimate of 91. The average target predicts an increase of 39.76% from the current stock price of 52.31.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for MBX Biosciences stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 9 | 9 | 9 | 9 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 11 | 11 | 12 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| LifeSci Capital | LifeSci Capital | Buy Maintains $91 | Buy | Maintains | $91 | +73.96% | Jun 18, 2026 |
| Truist Financial | Truist Financial | Buy Reiterates $70 | Buy | Reiterates | $70 | +33.82% | Jun 15, 2026 |
Unknown Analyst Oppenheimer No rating | Oppenheimer | Buy Reiterates $80 | Buy | Reiterates | $80 | +52.93% | Jun 15, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $88 | Buy | Reiterates | $88 | +68.23% | Jun 15, 2026 |
| Barclays | Barclays | Buy Maintains $70 | Buy | Maintains | $70 | +33.82% | Jun 15, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.75
from -2.38
EPS Next Year
-3.94
from -2.75
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -2.32 | -3.17 | |
| Avg | -2.75 | -3.94 | |
| Low | -3.22 | -7.04 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.